What Are the Treatment Options for Cancers with BRAF V600E Mutation?
Targeted therapies have shown promise in treating cancers with the BRAF V600E mutation:
BRAF Inhibitors: Drugs like vemurafenib and dabrafenib specifically inhibit the mutant BRAF protein, reducing tumor growth. MEK Inhibitors: Often used in combination with BRAF inhibitors, drugs like trametinib target the downstream MEK proteins in the pathway. Combination Therapies: Combining BRAF and MEK inhibitors has been more effective than using either alone, improving overall survival rates.
